Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| IGC Pharma, Inc. | 1,371,251 | reported | 19 Jan 2026 | tx 380+6,456,250−2,518,250 |
| Amphastar Pharmaceuticals, Inc. | 39,362 | reported | 25 Nov 2025 | tx 151+524,149−598,622 |
| STEELCLOUD INC | 13,600 | reported | 31 Oct 2003 | tx 4+35,000−70,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Jan 2026 | EXERCISE | IGC Pharma, Inc. | 100,000 | 0.00 USD | |
| 19 Jan 2026 | EXERCISE | IGC Pharma, Inc. | 100,000 | 0.00 USD | deriv |
| 25 Nov 2025 | SALE | Amphastar Pharmaceuticals, Inc. | 4,179 | 27.10 USD | |
| 25 Nov 2025 | EXERCISE | Amphastar Pharmaceuticals, Inc. | 4,179 | 16.69 USD | |
| 25 Nov 2025 | EXERCISE | Amphastar Pharmaceuticals, Inc. | 4,179 | 0.00 USD | deriv |
| 17 Oct 2025 | GRANT_AWARD | IGC Pharma, Inc. | 750,000 | 0.00 USD | deriv |
| 02 Jun 2025 | GRANT_AWARD | Amphastar Pharmaceuticals, Inc. | 5,122 | 0.00 USD | |
| 02 Jun 2025 | GRANT_AWARD | Amphastar Pharmaceuticals, Inc. | 11,402 | 0.00 USD | deriv |
| 31 Mar 2025 | EXERCISE | IGC Pharma, Inc. | 58,333 | 0.00 USD | |
| 31 Mar 2025 | EXERCISE | IGC Pharma, Inc. | 100,000 | 0.00 USD | |
| 31 Mar 2025 | EXERCISE | IGC Pharma, Inc. | 70,000 | 0.00 USD | |
| 31 Mar 2025 | EXERCISE | IGC Pharma, Inc. | 58,333 | 0.00 USD | deriv |
| 31 Mar 2025 | EXERCISE | IGC Pharma, Inc. | 70,000 | 0.00 USD | deriv |
| 31 Mar 2025 | EXERCISE | IGC Pharma, Inc. | 100,000 | 0.00 USD | deriv |
| 09 Dec 2024 | EXERCISE | Amphastar Pharmaceuticals, Inc. | 10,000 | 19.52 USD | |
| 09 Dec 2024 | GIFT | Amphastar Pharmaceuticals, Inc. | 410 | 0.00 USD | |
| 09 Dec 2024 | SALE | Amphastar Pharmaceuticals, Inc. | 10,000 | 43.77 USD | |
| 09 Dec 2024 | EXERCISE | Amphastar Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 12 Nov 2024 | SALE | Amphastar Pharmaceuticals, Inc. | 5,000 | 48.80 USD | |
| 12 Nov 2024 | GIFT | Amphastar Pharmaceuticals, Inc. | 1,000 | 0.00 USD | |
| 12 Nov 2024 | EXERCISE | Amphastar Pharmaceuticals, Inc. | 2,500 | 16.69 USD | |
| 12 Nov 2024 | EXERCISE | Amphastar Pharmaceuticals, Inc. | 2,500 | 0.00 USD | deriv |
| 12 Aug 2024 | EXERCISE | Amphastar Pharmaceuticals, Inc. | 3,915 | 20.03 USD | |
| 12 Aug 2024 | SALE | Amphastar Pharmaceuticals, Inc. | 17,101 | 43.07 USD | |
| 12 Aug 2024 | EXERCISE | Amphastar Pharmaceuticals, Inc. | 7,182 | 19.52 USD |
1 purchase reported after at least 12 months of silence — most recent on 15 Aug 2014.